133 followers
RT @esragbilir: 🚨@AnnSurgOncol ❗️primary therapeutic strategy using complete CRS/HIPEC (n=15) in ovarian pseudomyxoma peritonei led to fav…
RT @esragbilir: 🚨@AnnSurgOncol ❗️primary therapeutic strategy using complete CRS/HIPEC (n=15) in ovarian pseudomyxoma peritonei led to fav…
RT @esragbilir: 🚨@AnnSurgOncol ❗️primary therapeutic strategy using complete CRS/HIPEC (n=15) in ovarian pseudomyxoma peritonei led to fav…
RT @esragbilir: 🚨@AnnSurgOncol ❗️primary therapeutic strategy using complete CRS/HIPEC (n=15) in ovarian pseudomyxoma peritonei led to fav…
RT @esragbilir: 🚨@AnnSurgOncol ❗️primary therapeutic strategy using complete CRS/HIPEC (n=15) in ovarian pseudomyxoma peritonei led to fav…